Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Jinchen Shao
ResearcherPublications, citations & collaboration network
Jinchen Shao is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 48 works, 932 citations, an h-index of 18 and an i10-index of 28.
48
Works
932
Citations
18
h-index
28
i10-index
IDs:OpenAlex
How has Jinchen Shao's publication output changed over time?
ScholarIQpublication output · 2014–2023
Output grew100% over the shown period — from 1 works in 2014 to 2 in 2023.
1
2
1
1
2
2
2
2014201720182019202120222023
What are the most-cited papers on Jinchen Shao?
ScholarIQmost cited works
Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
Jun Liu, Yang Yang, Zhichao Liu, Xiaolong Fu, Xiaoyue Cai, Hongxuan Li, Li Zhu, Yan Shen, Hong Zhang, Yifeng Sun, Hezhong Chen, Bentong Yu, Renquan Zhang, Jinchen Shao, Ming Zhang, Zhigang Li
S2754803477. 2022282 CitationsOPEN ACCESS
Two-year outcomes of clinical N2-3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study
Yang Yang, Jun Liu, Zhichao Liu, Li Zhu, Hezhong Chen, Bentong Yu, Renquan Zhang, Jinchen Shao, Ming Zhang, Chun Guang Li, Zhigang Li
Journal of Thoracic and Cardiovascular Surgery. 202353 Citations
Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma
Chan Xiang, Min Zhang, Zhanxian Shang, Shengnan Chen, Jikai Zhao, Bowen Ding, Dong Jiang, Qian Zhu, Haohua Teng, Lei Zhu, Jinchen Shao, Ruiying Zhao, Min Ye, Yu Yang, Yuchen Han
Cell Death and Disease. 202352 CitationsOPEN ACCESS
Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study)
Yang Yang, Li Zhu, Yan Cheng, Zhichao Liu, Xiaoyue Cai, Jinchen Shao, Ming Zhang, Jun Liu, Yifeng Sun, Yin Li, Jun Yi, Bentong Yu, Hongjing Jiang, Hezhong Chen, Hong Yang, Lijie Tan, Zhigang Li
BMC Cancer. 202236 CitationsOPEN ACCESS
Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry
Jie Zhang, Chan Xiang, Yuchen Han, Haohua Teng, Xiaojing Li, Jinchen Shao, Lei Zhu, Han Han‐Zhang, Junyi Ye, Keke Yu
Journal of Cancer Research and Clinical Oncology. 201832 CitationsOPEN ACCESS
Related on ScholarIQ
Shanghai Jiao Tong University
Institution
Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
Paper
Two-year outcomes of clinical N2-3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study
Paper
Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma
Paper
Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study)
Paper
Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry
Paper